JP2005538041A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538041A5
JP2005538041A5 JP2003578426A JP2003578426A JP2005538041A5 JP 2005538041 A5 JP2005538041 A5 JP 2005538041A5 JP 2003578426 A JP2003578426 A JP 2003578426A JP 2003578426 A JP2003578426 A JP 2003578426A JP 2005538041 A5 JP2005538041 A5 JP 2005538041A5
Authority
JP
Japan
Prior art keywords
sema4a
protein
mammalian
cell
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003578426A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538041A (ja
Filing date
Publication date
Priority claimed from DE10213762A external-priority patent/DE10213762A1/de
Application filed filed Critical
Publication of JP2005538041A publication Critical patent/JP2005538041A/ja
Publication of JP2005538041A5 publication Critical patent/JP2005538041A5/ja
Pending legal-status Critical Current

Links

JP2003578426A 2002-03-26 2003-03-18 共刺激分子及びその使用 Pending JP2005538041A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10213762A DE10213762A1 (de) 2002-03-26 2002-03-26 Neues costimulierendes Molekül und dessen Verwendung
PCT/EP2003/002785 WO2003080673A1 (en) 2002-03-26 2003-03-18 Costimulatory molecule and its use

Publications (2)

Publication Number Publication Date
JP2005538041A JP2005538041A (ja) 2005-12-15
JP2005538041A5 true JP2005538041A5 (https=) 2006-05-11

Family

ID=27816004

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003578426A Pending JP2005538041A (ja) 2002-03-26 2003-03-18 共刺激分子及びその使用

Country Status (5)

Country Link
EP (1) EP1490406A1 (https=)
JP (1) JP2005538041A (https=)
AU (1) AU2003219068A1 (https=)
DE (1) DE10213762A1 (https=)
WO (1) WO2003080673A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003686A (es) 2003-10-03 2007-03-01 Brigham & Womens Hospital Ligandos tim-3 y sus metodos.
TW200539890A (en) 2004-03-12 2005-12-16 Brigham & Womens Hospital Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
DE202006007590U1 (de) 2006-05-12 2006-12-14 Osaka University Verwendung einer Zusammensetzung, die Sema7A- und VLA-1-Interaktion inhibiert, zum Behandeln von Cytokin-vermittelten Erkrankungen
WO2008055889A1 (en) * 2006-11-10 2008-05-15 Osaka University Compositions and methods of treating oncological, inflammatory and autoimmune diseases mediated by sema4a

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002538841A (ja) * 1999-03-18 2002-11-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ２７個のヒト分泌タンパク質
US7033780B1 (en) * 1999-06-14 2006-04-25 Millennium Pharmaceuticals, Inc. Nucleic acids corresponding to TANGO 294 a gene encoding a lipase—like protein
WO2002006339A2 (en) * 2000-07-03 2002-01-24 Curagen Corporation Proteins and nucleic acids encoding same
WO2002062841A2 (en) * 2001-02-02 2002-08-15 Incyte Genomics, Inc. Secreted proteins

Similar Documents

Publication Publication Date Title
JPH07503851A (ja) 改良インターフェロン及びヒトの末梢血液白血球からのその製造方法
US5834429A (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens
TW200808346A (en) Cat dander allergen treatments
JPH01501939A (ja) 免疫抑制ペプチドおよび使用法
JPH01502194A (ja) 肝細胞内で亜三日熱マラリヤ原虫により生成されたタンパク質の特微的なエピトープを単数又は複数有する少なくとも１つのペプチド配列を含む分子、及びこれらの分子を含む化合物
CA2361658C (en) T helper cell epitopes
WO2021201612A1 (ko) 신규 코로나바이러스 예방 및 치료용 백신 조성물
EP0249390A2 (en) Synthetic peptides related to the HIV glycoprotein gp 120
EA027803B1 (ru) ИММУНОГЕННЫЕ СОЕДИНЕНИЯ, ВКЛЮЧАЮЩИЕ ПЕПТИД gp41 ВИЧ, СВЯЗАННЫЙ С БЕЛКОМ-НОСИТЕЛЕМ CRM197
JP5802553B2 (ja) ペプチジルジアシルグリセリド
US9839669B2 (en) Antiviral agent comprising recombinant mistletoe lectins
JP2005538041A5 (https=)
JP2010029217A (ja) Ｈｉｖ特異的ｃｔｌを誘導し得るペプチド及び該ペプチドを含む抗ａｉｄｓ予防・治療剤
CN113185586B (zh) SARS-CoV-2编码蛋白来源的T细胞表位多肽及其应用
JP5836968B2 (ja) ＩｇＥ媒介性疾患の処置方法
CN116059348A (zh) 基于nkg2d的细胞接合器分子在清除衰老细胞中的应用
US11344611B2 (en) Polypeptide, compositions and uses thereof
DK173667B1 (da) Små peptider, der hæmmer binding til T-4 receptorer og virker som immunogener, farmaceutisk produkt som omfatter mindst 1 af peptiderne samt prøveudstyr til påvisning af antistoffer
JP3716298B2 (ja) 新規な降圧ペプチド
JP2006508901A (ja) Ｔ細胞非結合性ペプチド及びその用途
JP2002255997A (ja) Ｃｄ８＋細胞傷害性ｔリンパ球エピトープペプチド及びその用途
Liu Natural and biotech‐derived therapeutic proteins: What is the future?
AU2018214451A1 (en) Immunostimulating compositions and uses therefore
AP96A (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens.
WO2024186803A3 (en) Nucleocapsid antigen immunotherapy for covid-19 fusion proteins and methods of use